What is the Paxzen Tablet for?
Paxzen Tablet (Nirmatrelvir tablets and ritonavir tablets) is designed to treat mild-to-moderate COVID-19 in adults and children (12 years and older, weighing at least 40 kg) with a positive COVID-19 test and at risk of severe disease. It inhibits the coronavirus’s replication in the body, curbing its ability to multiply.
Use of the medicine?
Paxzen Tablet is beneficial for individuals with mild COVID symptoms at high risk of severe disease. Nirmatrelvir tablets, an antiviral, impedes the virus’s spread, while ritonavir tablets, a booster, enhances Nirmatrelvir’s availability in the body, optimizing the effectiveness of this combined medication.
Working
Nirmatrelvir tablet work by halting the virus’s replication. To be effective, it should be initiated within five days of the onset of COVID symptoms.
Dosage
Dosage is determined by your medical condition and response to treatment. For optimal results, start taking the medication within 5 days of symptom onset, and take it at evenly spaced times each day to aid in remembering.
Overdosage
In case of an overdose with serious symptoms like loss of consciousness or difficulty breathing, seek immediate medical attention.
How to use it?
Take this medication orally as directed by your doctor, with or without food. Typically, it is taken once in the morning and once in the evening for 5 days.
Side Effects of Paxzen Tablet
Transient side effects of nirmatrelvir tablets/ritonavir tablets may include dysgeusia (altered taste), diarrhea, hypertension, myalgia (muscle pain), and vomiting. Promptly consult a doctor in case of concerning episodes.
Drug Interactions
Nirmatrelvir/ritonavir tablets may impact the elimination of other medications from your body, potentially altering their effectiveness. Drugs such as alfuzosin, certain antiarrhythmics (like amiodarone, flecainide, propafenone, quinidine), azole antifungals (such as voriconazole), specific benzodiazepines (midazolam, triazolam), certain “blood thinners” (like rivaroxaban, warfarin), eletriptan, medications for erectile dysfunction(ED) or pulmonary hypertension (such as avanafil, sildenafil), ergot alkaloids (like dihydroergotamine, ergonovine, ergotamine, methylergonovine), lurasidone, certain opioid pain medications (such as fentanyl, meperidine), pimozide, ranolazine, salmeterol, “statin” cholesterol drugs (such as simvastatin, lovastatin), and others may be affected.
Precaution
Prior to using this product, inform your doctor or pharmacist if you are allergic to nirmatrelvir tablets and ritonavir tablets, or have other allergies. The product may contain inactive ingredients that can cause allergic reactions. Discuss your medical history, including kidney disease, liver disease, and HIV infection, with your healthcare provider. To prevent virus transmission, continue practicing precautions such as self-isolation, mask-wearing, social distancing, hand hygiene, and avoiding item sharing. Before undergoing surgery, disclose all products you use. During pregnancy, use this product only when clearly necessary after discussing risks and benefits with your doctor.
FAQs
1. Do HIV medications interact with Paxzen Tablets?
Yes, using Paxzen Tablets may reduce the effectiveness of HIV medications. It is advised to take Paxzen Tablets exclusively as directed by a physician. Avoid self-medication.
2. Is it necessary to use the nirmatrelvir tablets for the entire recommended course?
Indeed. Always take nirmatrelvir tablets
according to the five-day recommended timetable. Missing a dosage could make your illness worse and have an impact on viral clearance. To reduce the danger of viral transmission, maintain isolation and take all necessary precautions, such as frequent hand sanitizer use, mask usage, and hand washing.
3. Are kids safe using Paxzen tablets?
No, Children should not take Paxzen Tablets since the effects of the tablet have not been investigated in children or people under the age of 18.
Short details about manufacturer
Zenara Pharma is a pharmaceutical company that provides opportunities for licensing, contract manufacturing, and pharmaceutical regulatory services in the European Union, the United States, and India. It is a subsidiary of Biophore India Pharmaceuticals and has a team of 51-200 employees.
